RDInvesting Provides Investors with Free In-Depth Equity Reports on DHI, EZCH, IRWD and NUE
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
D.R. Horton, Inc. (NYSE: DHI) shares declined 2.75 percent to close at $21.20 a share Wednesday. The stock traded between $21.08 and $22.24 on volume of 7.81 million shares traded. Analysts at Compass Point have recently upgraded the company’s rating to “buy” from “neutral”. Shares of D.R. Horton have gained approximately 7.2 percent year-to-date.
Find out more about D.R. Horton including full access to the free equity report at:
www.RDInvesting.com/DHI
EZchip Semiconductor Ltd. (NASDAQ: EZCH) shares increased 2.71 percent to close at $28.40 a share Wednesday. The stock traded between $27.74 and $29.50 on volume of 336,297 shares traded. Analysts at Chardan Capital Markets have recently upgraded the company’s rating to “hold” from “sell”. Shares of EZchip Semiconductor have fallen approximately 14.12 percent year-to-date.
Find out more about EZchip Semiconductor including full access to the free equity report at:
www.RDInvesting.com/EZCH
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares increased 2.21 percent to close at $11.54 a share Wednesday. The stock traded between $11.44 and $12.00 on volume of 1.65 million shares traded. Analysts at Cantor Fitzgeraldhave recently upgraded the company’s rating to “hold” from “sell”. Shares of Ironwood Pharmaceuticals have fallen approximately 4.2 percent year-to-date.
Find out more about Ironwood Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/IRWD
Nucor Corporation (NYSE: NUE) shares declined 1.42 percent to close at $45.84 a share Wednesday. The stock traded between $45.43 and $46.27 on volume of 2.41 million shares traded. Analysts at Argus have recently downgraded the company’s rating to “hold” from “buy”. Shares of Nucor have gained approximately 7.2 percent year-to-date.
Find out more about Nucor including full access to the free equity report at:
www.RDInvesting.com/NUE
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com